Journal of Gastroenterology and Hepatology · 2003 · 75 citations · 25 references
MedicineOncologyToxicologyCarcinogenesisGastroenterologyNeoplasiaCarcinogenicity AssessmentGastric CancerGastric DiseasesGastric DisordersOxidative Stress In CarcinogenesisDouble-contrast RadiographyGastric PathologyHelicobacter Pylori InfectionHelicobacter Pylori-associated Gastric CarcinogenesisHelicobacter-associated Gastric CarcinogenesisOxidative Dna Damage
BACKGROUND AND AIM: The severe inflammation, increased cell proliferation and marked acid inhibition observed in subjects with Helicobacter pylori-associated enlarged-fold gastritis suggest that enlarged-fold gastritis may be a risk factor for gastric carcinoma. The purpose of the present study was to determine whether a relationship exists between enlarged-fold gastritis and gastric carcinoma. METHODS: One hundred and thirty-five H. pylori-positive patients with early gastric carcinoma and 141 age- and sex-matched H. pylori-positive controls without gastric carcinoma were involved in the study. The widths of gastric body folds were measured by double-contrast radiographs. The mutagenicity of gastric juice was assayed using the Ames test and Salmonella typhimurium TA-98 or TA-100 with S9-mix. Levels of 8-hydroxydeoxyguanosine (8-OHdG) in gastric mucosa were examined using high-performance liquid chromatographic-electrochemical detection. RESULTS: An upward shift in the distribution of gastric fold widths in H. pylori-positive patients with early gastric carcinoma was found. Enlarged-fold gastritis (fold width >/=5 mm) was observed in 81% of the patients with gastric carcinoma, compared with 46% of H. pylori-positive controls. The odds ratio for gastric carcinoma increased with increasing fold width to a maximum of 35.5 in persons with fold width >/=7 mm. The prevalence of diffuse-type early gastric carcinoma in the body region increased with increasing fold width. The mutagenicity of gastric juice from the patients with enlarged-fold gastritis was significantly higher than that in H. pylori-negative controls and H. pylori-positive patients without enlarged folds. Mucosal 8-OHdG levels in the body region of patients with enlarged-fold gastritis were significantly higher than in H. pylori-negative controls and H. pylori-positive patients without enlarged-fold gastritis. Eradication of H. pylori significantly decreased the mutagenicity of gastric juice and 8-OHdG levels in the gastric mucosa from patients with enlarged-fold gastritis. CONCLUSION: A significant association is suggested between enlarged-fold gastritis and gastric carcinoma.
25
<i>Helicobacter pylori</i> Infection and the Development of Gastric Cancer
Naomi Uemura, Shiro Okamoto, Soichiro Yamamoto et al. · New England Journal of Medicine · 2001 · 4.5K citations · Full text
Medicine, Microbiology, Oncology +15
Campylobacter pyloridis-associated chronic active antral gastritis
Erik A.J. Rauws, W. Langenberg, H. J. Houthoff et al. · Gastroenterology · 1988 · 596 citations
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.
Gareth Davies, Nicola Simmonds, Tim Stevens et al. · Gut · 1994 · 415 citations · Full text
Medicine, Pathobiology, Pathology +15
Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
Barry J. Marshall, Jim Warren, Graham J. Francis et al. · PubMed · 1987 · 394 citations